FDA Approves Drug for Treatment of Erythropoietic Protoporphyria
NIH Creates New Vector for Improved Gene Therapy in Sickle Cell Disease
New NIH-funded Research Centers Speed and Diversify Alzheimer’s Drug Discovery
Emerging Parasitic Disease Discovered
2019 NIH Director's High-Risk, High-Reward Research Program Recipients Announced